Cargando…
Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease
BACKGROUND: Agranulocytosis is regarded as a rare side effect of methimazole (MMI) therapy that occurs in a dose dependent manner and that usually develops within the first 3–6 months of treatment. Although delayed development beyond this timeline has been documented in adults, very few children hav...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013617/ https://www.ncbi.nlm.nih.gov/pubmed/27605984 http://dx.doi.org/10.1186/s13633-016-0034-6 |